Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cerebral imaging and depressive disorder].

J L Martinot1, P Peron-Magnan

  • 1Service Hospitalier Frédéric Joliot, CEA, Département de Biologie, Hôpital d'Orsay.

L'Encephale
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disentangling the autism-anxiety overlap: fMRI of reward processing in a community-based longitudinal study.

Translational psychiatry·2016
Same author

[Value of brain imaging in assessment of cognitive symptoms. Cognitive and emotional impact of antipsychotic drug treatment]].

L'Encephale·2006
Same author

Modulation of language areas with functional MR image-guided magnetic stimulation.

NeuroImage·2005
Same author

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia.

The British journal of psychiatry : the journal of mental science·2001
Same author

Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia.

Schizophrenia research·2001
Same author

In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia.

Journal of clinical psychopharmacology·2001

Cerebral imaging studies reveal reduced brain activity in depressed individuals. While computed tomography shows no widespread defects, advanced techniques like PET scans indicate lower blood flow and glucose consumption in depressed patients.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Cerebral imaging has been explored since the 1980s to identify organic or functional anomalies in depressive syndromes.
  • Fewer studies exist for depression compared to schizophrenia.

Purpose of the Study:

  • To review the findings of various cerebral imaging techniques in depressive states.
  • To assess the utility of techniques like CT, scintiscan, PET, and EEG mapping in diagnosing depression and ruling out other conditions.

Main Methods:

  • Review of studies utilizing computed tomography (CT), scintiscan, positron emission tomography (PET), and electroencephalography (EEG) mapping.
  • Comparative case-control studies and functional imaging techniques (e.g., Xenon 133 test for cerebral blood flow, PET for glucose consumption).

Related Experiment Videos

Main Results:

  • CT scans generally show no cerebral defects in depressed patients, except for some subtypes (aged, delusional/hallucinatory) exhibiting cortico-subcortical atrophy.
  • Scintiscan and PET scans indicate decreased cerebral blood flow and, under specific conditions, reduced glucose consumption in depressed subjects.
  • EEG mapping has primarily identified abnormalities in organic brain syndromes, particularly dementia, which requires exclusion in depression diagnosis.

Conclusions:

  • Cerebral imaging, particularly PET and scintiscan, suggests functional alterations like reduced blood flow and glucose metabolism in depression.
  • CT is less conclusive, though atrophy may be seen in specific patient groups.
  • EEG mapping is crucial for differentiating depression from dementia, especially in involutional depression.